BA-HUMAB

Serial Number 97277274
Registration 7186066
700

Registration Progress

Application Filed
Feb 21, 2022
Under Examination
Approved for Publication
Jul 25, 2023
Published for Opposition
Jul 25, 2023
Registered
Oct 10, 2023

Trademark Image

BA-HUMAB

Basic Information

Serial Number
97277274
Registration Number
7186066
Filing Date
February 21, 2022
Registration Date
October 10, 2023
Published for Opposition
July 25, 2023
Drawing Code
5

Status Summary

Current Status
Active
Status Code
700
Status Date
Oct 10, 2023
Registration
Registered
Classes
042

Rights Holder

Shandong Boan Biotechnology Co., Ltd.

99
Address
NO.39, KEJI AVENUE, HIGH-TECH ZONE
YANTAI
SHANDONG PROVINCE 264670
CN

Ownership History

Shandong Boan Biotechnology Co., Ltd.

Original Applicant
99
SHANDONG PROVINCE CN

Shandong Boan Biotechnology Co., Ltd.

Owner at Publication
99
SHANDONG PROVINCE CN

Shandong Boan Biotechnology Co., Ltd.

Original Registrant
99
SHANDONG PROVINCE CN

Legal Representation

Attorney
John Alumit

USPTO Deadlines

Next Deadline
1430 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-10-10)
Due Date
October 10, 2029
Grace Period Ends
April 10, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

24 events
Date Code Type Description Documents
Oct 10, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Oct 10, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jul 25, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 25, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 5, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 9, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jun 9, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jun 9, 2023 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Jun 9, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 9, 2023 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
May 4, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 4, 2023 ALIE A ASSIGNED TO LIE Loading...
May 4, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 2, 2023 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Jan 17, 2023 RCCK S SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Loading...
Jan 17, 2023 GNS2 O NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Loading...
Jan 17, 2023 GNSI S INQUIRY TO SUSPENSION E-MAILED Loading...
Jan 17, 2023 CNSI R SUSPENSION INQUIRY WRITTEN Loading...
May 26, 2022 GNSL F LETTER OF SUSPENSION E-MAILED Loading...
May 26, 2022 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
May 26, 2022 CNSL R SUSPENSION LETTER WRITTEN Loading...
May 24, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 24, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 24, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Early evaluation services in the field of new drugs; Consulting services in the field of technology development; Research and development services in the field of antibodies; Development of pharmaceutical preparations and medicines; Pharmaceutical drug development services; biochemical research and analysis; Research and development of new products; Pharmaceutical research services; Research and development of new products for others; Research and development of pharmaceuticals

Additional Information

Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
042